MYH11 and neoplasm: As shown in Figure 4, the relative expression levels of MYH11 and CD20 were elevated in stages III/IV compared with stages I/II in both ESCA and STAD samples (Figure 4A,C) and were positively correlated with tumour stage (p < 0.05, Figure 4B,D).